Publications

Comparative Study
Journal Article
Ppublish 1159 citations
Electronic publication date
October 2, 2009

View on Pubmed.gov 19235886 | View on doi.org 10.1002/ibd.209...

Low counts of Faecalibacterium prausnitzii in colitis microbiota.

Search for publications in this journal Inflamm Bowel Dis - 15(8):1183-9

Abstract

BACKGROUND

The intestinal microbiota is suspected to play a role in colitis and particularly in inflammatory bowel disease (IBD) pathogenesis. The aim was to compare the fecal microbiota composition of patients with colitis to that of healthy subjects (HS).

METHODS

fecal samples from 22 active Crohn's disease (A-CD) patients, 10 CD patients in remission (R-CD), 13 active ulcerative colitis (A-UC) patients, 4 UC patients in remission (R-UC), 8 infectious colitis (IC) patients, and 27 HS were analyzed by quantitative real-time polymerase chain reaction (PCR) targeting the 16S rRNA gene. Bacterial counts were transformed to logarithms (Log(10) CFU) for statistical analysis.

RESULTS

Bacteria of the phylum Firmicutes (Clostridium leptum and Clostridium coccoides groups) were less represented in A-IBD patients (9.7; P = 0.004) and IC (9.4; P = 0.02), compared to HS (10.8). Faecalibacterium prausnitzii species (a major representative of the C. leptum group) had lower counts in A-IBD and IC patients compared to HS (8.8 and 8.3 versus 10.4; P = 0.0004 and P = 0.003). The Firmicutes/Bacteroidetes ratio was lower in A-IBD (1.3; P = 0.0001) and IC patients (0.4; P = 0.002). Compared to HS, Bifidobacteria were less represented in A-IBD and IC (7.9 and 7.7 versus 9.2; P = 0.001 and P = 0.01).

CONCLUSIONS

The fecal microbiota of patients with IBD differs from that of HS. The phylum Firmicutes and particularly the species F. prausnitzii, are underrepresented in A-IBD patients as well as in IC patients. These bacteria could be crucial to gut homeostasis since lower counts of F. prausnitzii are consistently associated with a reduced protection of the gut mucosa.

References

No references provided.

Cited by 1159 citations (total)

Journal Article

Identification of New Potential Biotherapeutics from Human Gut Microbiota-Derived Bacteria.

Electronic publication date April 4, 2021

Search for publications in this journal Microorganisms

Bernardo Cuffaro [...] Emmanuelle Maguin et al.

The role of the gut microbiota in health and disease is well recognized and the microbiota dysbiosis observed in many...

Journal Article Research Support, Non-U.S. Gov't

Towards the human colorectal cancer microbiome.

Electronic publication date September 23, 2011

Search for publications in this journal PLoS One

Julian R Marchesi [...] Harold Tjalsma et al.

Multiple factors drive the progression from healthy mucosa towards sporadic colorectal carcinomas and accumulating evidence associates intestinal bacteria with disease...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances